Your browser doesn't support javascript.
loading
Study of the prevalence of tumour-related asthenia in Spanish cancer patients
González Barón, M; Feyjóo, M; Carulla Torrent, J; Camps, C; Escobar, Y; Belda-Iniesta, C.
Afiliación
  • González Barón, M; University Hospital La Paz. Madrid. Spain
  • Feyjóo, M; Hospital La Moraleja. Madrid. Spain
  • Carulla Torrent, J; Hospital Universitari Vall d´Hebrón. Barcelona. Spain
  • Camps, C; Valencia General Hospital. Valencia. Spain
  • Escobar, Y; University Hospital Gregorio Marañón. Madrid. Spain
  • Belda-Iniesta, C; University Hospital La Paz. Madrid. Spain
Clin. transl. oncol. (Print) ; Clin. transl. oncol. (Print);10(6): 351-358, jun. 2008. tab, ilus
Article en En | IBECS | ID: ibc-123459
Biblioteca responsable: ES1.1
Ubicación: BNCS
ABSTRACT
INTRODUCTION: Asthenia is the most prevalent symptom in oncological patients but it is underestimated by the majority of healthcare professionals. The aim of the present study is to estimate the prevalence of tumour-related asthenia in the Spanish population, while defining the associated factors. METHODS: An epidemiological, multicentre, cross-sectional study was conducted in oncology services from Spain, including 712 cancer patients (58.4+/-13.5 years). RESULTS: 42.5% patients showed asthenia. This prevalence appeared to be tumour-related (p<0.05) and increased among patients with a more advanced stage of disease or with a worsening of performance status (p<0.001). The prevalence of asthenia increased in the presence of the following factors: chemotherapy (in the past: 52.1% vs. 31.0%; at the time of the study: 46.1% vs. 38.2%), symptomatic treatment (in the past: 60.4% vs. 39.8%; at the time of the study: 61.3% vs. 38.6%), present interferon treatment (100%), anaemia (59.7% vs. 31.3%), dehydration/waterelectrolyte imbalance (58.3% vs. 41.6%), respiratory failure (61.4% vs. 39.7%), liver disease (59.5% vs. 41.3%), malnutrition (76.1% vs. 38.7%), pain (57.7% vs. 27.0%), anxiety (56.1% vs. 38.6%), depression (57.9% vs. 40.0%) and sleep disturbances (51.1% vs. 39.4%). A multivariate logistic regression showed that a model including performance status, patient circumstance, chemotherapy, anaemia, pain and anxiety correctly diagnosed asthenia in 70.9% of cases. CONCLUSIONS: The physiopathology of tumour-related asthenia remains relatively unknown, despite its high prevalence and considerable quality of life impact. Determining factors related to asthenia in clinical practice can favour the use of concrete treatments and improve the conditions of cancer patients (AU)
RESUMEN
No disponible
Asunto(s)
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Astenia / Estudios Multicéntricos como Asunto / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2008 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Astenia / Estudios Multicéntricos como Asunto / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2008 Tipo del documento: Article